Eton Pharmaceuticals (ETON) Inventory (2019 - 2025)

Eton Pharmaceuticals has disclosed Inventory across 7 years of filings, most recently posting $15.4 million for Q4 2025.

• Inventory for Q4 2025 came in at $15.4 million, up 1.23% year-over-year; the trailing twelve-month figure through Dec 2025 was $15.4 million (up 1.23% YoY), and the FY2025 annual result was $15.4 million, up 1.23% from the prior year.
• Inventory came in at $15.4 million for Q4 2025 at Eton Pharmaceuticals, down from $16.9 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $23.8 million in Q2 2025 to a low of $334000.0 in Q3 2021.
• The 5-year median for Inventory is $1.1 million (2021), against an average of $5.0 million.
• Across the five-year window, Inventory sank 80.34% in 2021 and surged 1572.01% in 2024, its largest moves.
• Eton Pharmaceuticals' Inventory stood at $550000.0 in 2021, then climbed by 1.27% to $557000.0 in 2022, then soared by 63.55% to $911000.0 in 2023, then soared by 1572.01% to $15.2 million in 2024, then rose by 1.23% to $15.4 million in 2025.
• The last three Inventory figures came in at $15.4 million (Q4 2025), $16.9 million (Q3 2025), and $23.8 million (Q2 2025), per Business Quant data.